Logo image of RGEN

REPLIGEN CORP (RGEN) Stock Analyst Earnings Estimates

NASDAQ:RGEN - Nasdaq - US7599161095 - Common Stock - Currency: USD

158.99  -3.68 (-2.26%)

After market: 158.99 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
RGEN revenue by date.RGEN revenue by date.
670.5M
83.05%
801.5M
19.54%
638.764M
-20.30%
646.83M
1.26%
708.76M
9.57%
816.48M
15.20%
965.03M
18.19%
1.14B
18.13%
1.439B
26.23%
1.734B
20.50%
2.072B
19.49%
2.476B
19.50%
EBITDA
YoY % growth
RGEN ebitda by date.RGEN ebitda by date.
216.2M
114.27%
247M
14.25%
154.861M
-37.30%
115.44M
-25.46%
139.88M
21.17%
179.9M
28.61%
256.25M
42.44%
314.37M
22.68%
373.2M
18.71%
456.24M
22.25%
525.9M
15.27%
613.86M
16.73%
EBIT
YoY % growth
RGEN ebit by date.RGEN ebit by date.
177.8M
140.92%
196M
10.24%
86.776M
-55.73%
83.612M
-3.65%
105.5M
26.18%
144.31M
36.79%
218.28M
51.26%
255.26M
16.94%
296.62M
16.20%
386.89M
30.43%
N/AN/A
Operating Margin
RGEN operating margin by date.RGEN operating margin by date.
26.52%24.45%13.58%12.93%14.89%17.67%22.62%22.39%20.61%22.31%N/AN/A
EPS
YoY % growth
RGEN eps by date.RGEN eps by date.
3.06
84.34%
3.28
7.19%
1.73
-47.26%
1.57
-14.45%
1.76
18.80%
2.26
28.57%
3.19
41.23%
3.54
10.86%
3.72
5.19%
4.69
26.03%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.37
33.57%
0.44
32.91%
0.43
-0.37%
0.51
16.24%
0.49
30.91%
0.53
21.51%
0.54
26.19%
0.60
17.66%
Revenue
Q2Q % growth
166.43M
9.99%
176.21M
14.37%
174.38M
12.62%
190.97M
13.98%
192.42M
15.62%
202.5M
14.92%
202.69M
16.23%
218.42M
14.37%
EBITDA
Q2Q % growth
31.416M
55.18%
36.209M
-20.00%
35.558M
-23.74%
41.043M
16.16%
41.434M
31.89%
45.812M
26.52%
44.238M
24.41%
52.291M
27.41%
EBIT
Q2Q % growth
21.418M
520.09%
26.443M
127.72%
25.794M
651.15%
32.369M
27.01%
32.248M
50.56%
36.605M
38.43%
34.862M
35.16%
42.68M
31.85%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
0.44
33.33%
0.420.025.21%
Q3 2024
Q2Q % growth
0.43
86.96%
0.340.0925.89%
Q2 2024
Q2Q % growth
0.33
-37.74%
0.330.00-0.80%
Q1 2024
Q2Q % growth
0.28
-56.25%
0.31-0.03-9.00%
Q4 2023
Q2Q % growth
0.33
-51.47%
0.330.00-0.62%
Q3 2023
Q2Q % growth
0.23
-70.13%
0.170.0635.96%
Q2 2023
Q2Q % growth
0.53
-41.76%
0.480.059.34%
Q1 2023
Q2Q % growth
0.64
-30.43%
0.600.046.89%
Q4 2022
Q2Q % growth
0.68
-16.05%
0.590.0915.49%
Q3 2022
Q2Q % growth
0.77
-1.28%
0.690.0811.01%
Q2 2022
Q2Q % growth
0.91
15.19%
0.730.1824.49%
Q1 2022
Q2Q % growth
0.92
35.29%
0.730.1925.27%
Q4 2021
Q2Q % growth
0.81
55.77%
0.660.1522.41%
Q3 2021
Q2Q % growth
0.78
95.00%
0.650.1320.19%
Q2 2021
Q2Q % growth
0.79
88.10%
0.530.2647.88%
Q1 2021
Q2Q % growth
0.68
112.50%
0.430.2557.79%
Q4 2020
Q2Q % growth
0.52
160.00%
0.310.2166.47%
Q3 2020
Q2Q % growth
0.40
53.85%
0.280.1241.94%
Q2 2020
Q2Q % growth
0.42
35.48%
0.280.1450.12%
Q1 2020
Q2Q % growth
0.32
14.29%
0.230.0941.80%
Q4 2019
Q2Q % growth
0.20 0.190.016.31%
Q3 2019
Q2Q % growth
0.26 0.200.0632.42%
Q2 2019
Q2Q % growth
0.31 0.250.0622.55%
Q1 2019
Q2Q % growth
0.28 0.210.0732.52%
RGEN Yearly EPS VS EstimatesRGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
167.55M
7.58%
171.02M-3.47M-2.03%
Q3 2024
Q2Q % growth
154.834M
9.66%
156.29M-1.456M-0.93%
Q2 2024
Q2Q % growth
154.073M
-3.20%
157.2M-3.127M-1.99%
Q1 2024
Q2Q % growth
151.31M
-17.16%
153.06M-1.75M-1.14%
Q4 2023
Q2Q % growth
155.743M
-16.63%
158.49M-2.747M-1.73%
Q3 2023
Q2Q % growth
141.192M
-29.65%
143.46M-2.268M-1.58%
Q2 2023
Q2Q % growth
159.169M
-23.33%
169.24M-10.071M-5.95%
Q1 2023
Q2Q % growth
182.66M
-11.50%
185.06M-2.4M-1.30%
Q4 2022
Q2Q % growth
186.8M
0.16%
188.25M-1.45M-0.77%
Q3 2022
Q2Q % growth
200.7M
12.63%
195.33M5.37M2.75%
Q2 2022
Q2Q % growth
207.6M
27.36%
193.12M14.48M7.50%
Q1 2022
Q2Q % growth
206.4M
44.54%
189.19M17.21M9.10%
Q4 2021
Q2Q % growth
186.5M
71.73%
182.88M3.62M1.98%
Q3 2021
Q2Q % growth
178.2M
89.37%
167.25M10.95M6.55%
Q2 2021
Q2Q % growth
163M
86.29%
147.13M15.87M10.79%
Q1 2021
Q2Q % growth
142.8M
87.65%
119.35M23.45M19.65%
Q4 2020
Q2Q % growth
108.6M
56.26%
95.754M12.846M13.42%
Q3 2020
Q2Q % growth
94.1M
35.59%
88.178M5.922M6.72%
Q2 2020
Q2Q % growth
87.5M
23.76%
79.948M7.552M9.45%
Q1 2020
Q2Q % growth
76.1M
25.58%
72.612M3.488M4.80%
Q4 2019
Q2Q % growth
69.5M 69.735M-235K-0.34%
Q3 2019
Q2Q % growth
69.4M 67.42M1.98M2.94%
Q2 2019
Q2Q % growth
70.7M 65.167M5.533M8.49%
Q1 2019
Q2Q % growth
60.6M 54.696M5.904M10.79%
RGEN Yearly Revenue VS EstimatesRGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.97% -10.61% -0.11% 7.48%
Revenue-0.05% -1.63% 0% 0.81%